Aclaris Therapeutics, Inc. (NASDAQ: ACRS) today announced the appointment of Bryan Reasons as a director and Chairman of the Audit ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE